BPC-157 Capsules contain the synthetic pentadecapeptide BPC-157 (Body Protection Compound-157) in an oral capsule formulation
HGF/c-Met pathway activity declines with age in the hippocampus, paralleling age-related cognitive decline
From that point, degradation begins, slowly at first but accelerating over time
Also in Japan, kidney dialysis patients with polyneuropathy received 5,000g methyl B12 shots, three times a week for six months
His work has recently appeared in the Cut, HuffPost, the Washington Post, and the San Francisco Chronicle
Protocols are typically structured around consistent use over a defined period to allow the body to fully respond to the therapy